Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Flexion Therapeutics Inc (NASDAQ:FLXN)

19.55
Delayed Data
As of Dec 09
 +0.06 / +0.31%
Today’s Change
7.56
Today|||52-Week Range
23.57
+1.45%
Year-to-Date
2 Red-Hot Biotechs to Buy Ahead of FDA Decisions
Nov 29 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close19.49
Today’s open19.62
Day’s range19.02 - 20.25
Volume417,293
Average volume (3 months)320,636
Market cap$608.5M
Dividend yield--
Data as of 4:00pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)-9.14%
Earnings growth (this year)-27.71%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.06

Competitors

 Today’s
change
Today’s
% change
GBTGlobal Blood Therape...0.000.00%
CLLSCellectis SA+0.37+2.16%
ACHNAchillion Pharmaceut...+0.11+2.60%
ENTAEnanta Pharmaceutica...+0.19+0.58%
Data as of 4:00pm ET, 12/09/2016

Financials

Next reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.72
Annual revenue (last year)$0.00
Annual profit (last year)-$46.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael D. Clayman
Chief Financial Officer
Frederick W. Driscoll
Corporate headquarters
Burlington, Massachusetts

Forecasts


Search for Jobs